CINECA IRIS Institutional Research Information System

SALAROGLIO, Iris Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.453
AS - Asia 3.189
EU - Europa 2.474
SA - Sud America 290
AF - Africa 76
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.301
CN - Cina 1.460
IT - Italia 924
SG - Singapore 836
BR - Brasile 220
SE - Svezia 196
DE - Germania 192
HK - Hong Kong 186
AT - Austria 177
IE - Irlanda 167
FR - Francia 164
JP - Giappone 127
GB - Regno Unito 123
VN - Vietnam 115
KR - Corea 100
IN - India 84
FI - Finlandia 79
CA - Canada 76
MX - Messico 69
ES - Italia 64
PL - Polonia 64
ID - Indonesia 63
TW - Taiwan 59
UA - Ucraina 58
NL - Olanda 55
BE - Belgio 52
RU - Federazione Russa 27
TR - Turchia 27
EG - Egitto 25
AU - Australia 24
PT - Portogallo 23
IR - Iran 22
AR - Argentina 21
CH - Svizzera 19
CO - Colombia 17
DK - Danimarca 17
GR - Grecia 17
CZ - Repubblica Ceca 16
BD - Bangladesh 15
EC - Ecuador 14
LB - Libano 13
IQ - Iraq 11
IL - Israele 10
ZA - Sudafrica 10
MA - Marocco 9
NO - Norvegia 9
SN - Senegal 9
CL - Cile 8
PK - Pakistan 8
HU - Ungheria 7
MO - Macao, regione amministrativa speciale della Cina 7
SA - Arabia Saudita 7
KE - Kenya 6
MY - Malesia 6
RO - Romania 6
TH - Thailandia 6
AM - Armenia 5
KZ - Kazakistan 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
JO - Giordania 4
MD - Moldavia 4
NG - Nigeria 4
VE - Venezuela 4
LV - Lettonia 3
NA - Namibia 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
DZ - Algeria 2
LT - Lituania 2
MU - Mauritius 2
SC - Seychelles 2
AD - Andorra 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EU - Europa 1
GN - Guinea 1
JM - Giamaica 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
TN - Tunisia 1
Totale 9.511
Salva come PNG Salva come JPEG
Città #
Singapore 453
Ashburn 319
Beijing 262
Chandler 252
Turin 212
Torino 206
Santa Clara 198
Fairfield 166
Vienna 165
Dublin 163
Dallas 138
Houston 118
Woodbridge 99
Ann Arbor 94
Guangzhou 84
Seoul 80
Seattle 79
Wilmington 78
Hefei 71
Los Angeles 66
Dearborn 64
Hong Kong 64
Cambridge 61
New York 61
Shanghai 60
Nyköping 58
Hangzhou 53
Pisa 48
Jakarta 47
Munich 47
Nanjing 47
Tokyo 47
Columbus 46
Milan 44
Redwood City 44
Princeton 38
Central 37
Taipei 37
Buffalo 35
Warsaw 34
Brussels 33
Helsinki 33
Medford 31
Changsha 30
Fremont 30
São Paulo 30
Boardman 28
Villeurbanne 28
Wuhan 28
Ho Chi Minh City 27
Bengaluru 25
Frankfurt am Main 25
Jacksonville 24
Boston 23
London 23
Shenzhen 23
Paris 21
Toronto 20
Jinan 19
Lappeenranta 19
Nuremberg 19
Amsterdam 18
Chengdu 18
Chongqing 18
Dong Ket 18
San Jose 18
Tianjin 18
Shenyang 17
Silver Spring 17
Hanoi 16
San Diego 16
Chicago 15
Montreal 15
Rome 15
Brescia 13
Las Vegas 13
Mexico City 13
Suzhou 13
Xian 13
Cairo 12
Osaka 12
Redondo Beach 12
Stockholm 12
Benito Juarez 11
Brno 11
Florence 11
Madrid 11
Phoenix 11
Wenzhou 11
Belo Horizonte 10
Brooklyn 10
Central District 10
Denver 10
Düsseldorf 10
Istanbul 10
Naples 10
Ottawa 10
Turku 10
Athens 9
Barcelona 9
Totale 5.320
Salva come PNG Salva come JPEG
Nome #
Impact of cancer metabolism on therapy resistance – Clinical implications 994
Hypoxia as a driver of resistance to immunotherapy 944
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 533
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 524
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma 349
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 327
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 326
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 325
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy 304
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 228
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 220
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer 182
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma 173
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 171
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment 170
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 168
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells 168
The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. 161
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 151
P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors 148
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro 144
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 140
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma 138
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 137
Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation 135
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells 126
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 126
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer 119
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer 116
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma 108
Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus 106
GIFC-2018 - BOOK OF ABSTRACTS 104
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer 101
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 99
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 98
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 97
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro 95
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells 93
Human and canine osteosarcoma cell lines: How do they react upon incubation with calcium phosphate-coated lipid nanoparticles carrying doxorubicin and curcumin? 88
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 88
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 88
A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound 70
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy 70
Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma 69
Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells 68
Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models 60
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression 57
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma 56
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition 54
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs 54
Smart hyaluronated micelles to enhance a gemcitabine prodrug efficacy 48
Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors 47
B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy 42
The blood-brain barrier/glioblastoma stem cells interaction is a key factor determining tumor chemoresistance: new therapeutic strategies to improve the pharmacological treatment of glioblastoma multiforme 39
Tailoring the Composition of HA/PEG Mixed Nano-Assemblies for Anticancer Drug Delivery 38
Totale 9.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.742
article - articoli 0
book - libri 0
conference - conferenze 1.843
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021567 0 0 0 0 83 72 51 57 60 85 84 75
2021/2022742 54 31 34 90 30 33 41 43 33 62 167 124
2022/20231.175 92 74 51 92 117 205 98 100 139 54 60 93
2023/20241.277 115 129 92 104 82 160 125 88 38 126 107 111
2024/20252.422 64 130 118 162 424 180 162 205 261 150 280 286
2025/20261.606 352 319 246 390 299 0 0 0 0 0 0 0
Totale 9.684